首页 > 最新文献

BMC Complementary Medicine and Therapies最新文献

英文 中文
Moringa oleifera flowers: insights into their aroma chemistry, anti-inflammatory, antioxidant, and enzyme inhibitory properties. 油辣木花:对其芳香化学、抗炎、抗氧化和酶抑制特性的深入研究。
IF 3.3 2区 医学 Q1 INTEGRATIVE & COMPLEMENTARY MEDICINE Pub Date : 2024-07-26 DOI: 10.1186/s12906-024-04579-y
Nouran M Fahmy, Shaimaa Fayez, Radwa Wahid Mohamed, Ahmed M Elissawy, Omayma A Eldahshan, Gokhan Zengin, Abdel Nasser B Singab

Background: Moringa oleifera is a highly nutritious plant widely used in traditional medicine.

Results: The aroma constituents present in the fresh flowers of M. oleifera versus the hydrodistilled oil and hexane extract were studied using GC-MS. Aldehydes were the major class detected in the fresh flowers (64.75%) with E-2-hexenal being the predominant component constituting > 50%. Alkane hydrocarbons, monoterpenes, and aldehydes constituted > 50% of the hydrodistilled oil, while alkane hydrocarbons exclusively constitute up to 65.48% of the hexane extract with heptacosane being the major component (46.2%). The cytotoxicity of the hexane extract was assessed on RAW 264.7 macrophages using the MTT assay which revealed no significant cytotoxicity at concentrations of 1 µg/mL and displayed IC50 value at 398.53 µg/mL as compared to celecoxib (anti-inflammatory drug) with IC50 value at 274.55 µg/ml. The hexane extract of Moringa flowers displayed good anti-inflammatory activity through suppression of NO, IL-6, and TNF-α in lipopolysaccharide-induced RAW 264.7 macrophages. The total phenolic and flavonoid content in the hexane extract was found to be 12.51 ± 0.28 mg GAE/g extract and 0.16 ± 0.01 mg RuE/g extract, respectively. It displayed moderate antioxidant activity as indicated by the in vitro DPPH, ABTS, CUPRAC, FRAP, and phosphomolybdenum (PBA) assays. No metal chelating properties were observed for the extract. The enzyme inhibitory potential of the hexane extract was evaluated on acetyl- and butyrylcholinesterases (for neuroprotective assessment), α-amylase and α-glucosidase (for antihyperglycemic assessment), and tyrosinase (for dermoprotective assessment) revealing promising results on cholinesterases, tyrosinase, and α-glucosidase.

Conclusion: Our findings suggested that M. oleifera leaves can be considered as a multidirectional ingredient for preparing functional applications.

背景油杉是一种营养价值很高的植物,被广泛用于传统医学:使用气相色谱-质谱(GC-MS)对油橄榄鲜花、水蒸馏油和正己烷提取物中的芳香成分进行了研究。在鲜花中检测到的主要成分是醛类(64.75%),其中最主要的成分是 E-2-己烯醛,占 50%以上。烷烃、单萜烯和醛类在水蒸馏油中的含量大于 50%,而烷烃在正己烷提取物中的含量高达 65.48%,其中庚烷是主要成分(46.2%)。用 MTT 法评估了正己烷提取物对 RAW 264.7 巨噬细胞的细胞毒性,结果显示,浓度为 1 µg/mL 时,细胞毒性不明显,IC50 值为 398.53 µg/mL,而塞来昔布(消炎药)的 IC50 值为 274.55 µg/ml。通过抑制脂多糖诱导的 RAW 264.7 巨噬细胞中的 NO、IL-6 和 TNF-α,辣木花的己烷提取物显示出良好的抗炎活性。正己烷提取物中的总酚和类黄酮含量分别为 12.51 ± 0.28 毫克 GAE/克提取物和 0.16 ± 0.01 毫克 RuE/克提取物。体外 DPPH、ABTS、CUPRAC、FRAP 和磷钼(PBA)检测表明,它具有中等程度的抗氧化活性。提取物没有金属螯合特性。评估了己烷提取物对乙酰胆碱酯酶和丁酰胆碱酯酶(用于神经保护评估)、α-淀粉酶和α-葡萄糖苷酶(用于降血糖评估)以及酪氨酸酶(用于皮肤保护评估)的酶抑制潜能,结果显示对胆碱酯酶、酪氨酸酶和α-葡萄糖苷酶的抑制效果良好:我们的研究结果表明,油橄榄叶可作为一种多用途成分用于制备功能性应用。
{"title":"Moringa oleifera flowers: insights into their aroma chemistry, anti-inflammatory, antioxidant, and enzyme inhibitory properties.","authors":"Nouran M Fahmy, Shaimaa Fayez, Radwa Wahid Mohamed, Ahmed M Elissawy, Omayma A Eldahshan, Gokhan Zengin, Abdel Nasser B Singab","doi":"10.1186/s12906-024-04579-y","DOIUrl":"10.1186/s12906-024-04579-y","url":null,"abstract":"<p><strong>Background: </strong>Moringa oleifera is a highly nutritious plant widely used in traditional medicine.</p><p><strong>Results: </strong>The aroma constituents present in the fresh flowers of M. oleifera versus the hydrodistilled oil and hexane extract were studied using GC-MS. Aldehydes were the major class detected in the fresh flowers (64.75%) with E-2-hexenal being the predominant component constituting > 50%. Alkane hydrocarbons, monoterpenes, and aldehydes constituted > 50% of the hydrodistilled oil, while alkane hydrocarbons exclusively constitute up to 65.48% of the hexane extract with heptacosane being the major component (46.2%). The cytotoxicity of the hexane extract was assessed on RAW 264.7 macrophages using the MTT assay which revealed no significant cytotoxicity at concentrations of 1 µg/mL and displayed IC<sub>50</sub> value at 398.53 µg/mL as compared to celecoxib (anti-inflammatory drug) with IC<sub>50</sub> value at 274.55 µg/ml. The hexane extract of Moringa flowers displayed good anti-inflammatory activity through suppression of NO, IL-6, and TNF-α in lipopolysaccharide-induced RAW 264.7 macrophages. The total phenolic and flavonoid content in the hexane extract was found to be 12.51 ± 0.28 mg GAE/g extract and 0.16 ± 0.01 mg RuE/g extract, respectively. It displayed moderate antioxidant activity as indicated by the in vitro DPPH, ABTS, CUPRAC, FRAP, and phosphomolybdenum (PBA) assays. No metal chelating properties were observed for the extract. The enzyme inhibitory potential of the hexane extract was evaluated on acetyl- and butyrylcholinesterases (for neuroprotective assessment), α-amylase and α-glucosidase (for antihyperglycemic assessment), and tyrosinase (for dermoprotective assessment) revealing promising results on cholinesterases, tyrosinase, and α-glucosidase.</p><p><strong>Conclusion: </strong>Our findings suggested that M. oleifera leaves can be considered as a multidirectional ingredient for preparing functional applications.</p>","PeriodicalId":9128,"journal":{"name":"BMC Complementary Medicine and Therapies","volume":null,"pages":null},"PeriodicalIF":3.3,"publicationDate":"2024-07-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11282830/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141765371","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Network pharmacology and experimental validation to explore the role and potential mechanism of Liuwei Dihuang Decoction in prostate cancer. 通过网络药理学和实验验证,探索六味地黄煎剂在前列腺癌中的作用和潜在机制。
IF 3.3 2区 医学 Q1 INTEGRATIVE & COMPLEMENTARY MEDICINE Pub Date : 2024-07-26 DOI: 10.1186/s12906-024-04572-5
Xiangyang Zhan, Haoze Li, Jingyun Jin, Xiran Ju, Jiawei Gao, Xinglin Chen, Fuwen Yuan, Jianyi Gu, DongLiang Xu, Guanqun Ju

Objective: To evaluate the anti-tumor effector of Liuwei Dihuang Decoction (LWDHD) in prostate cancer (PCa) and explore the potential mechanism using experimental validation, network pharmacology, bioinformatics analysis, and molecular docking.

Methods: CCK test, Clone formation assay and wound-healing assays were used to determine the effect of LWDHD on prostate cancer growth and metastasis. The active ingredients and targets of LWDHD were obtained from the TCMSP database, and the relevant targets were selected by GeneCards, OMIM and DisGeNET databases for PCa. The cross-targets of drugs and disease were imported into the STRING database to construct protein interactions. The network was also visualized using Cytoscape software and core targets are screened using the Network Analyzer plug-in. The Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment were analyzed using R software. TCGA database was used to analyze the correlation of bioinformatics genes. AutoDock vina was used to predict the molecular docking and binding ability of active ingredients to key targets. Through WB and q-PCR experiments, the above gene targets were detected to verify the effect of LWDHD on PCa.

Results: CCK and scratch tests confirmed that LWDHD could inhibit the proliferation, invasion and migration of prostate cancer cells. Clone formation experiments showed that LWDHD inhibited the long-term proliferative capacity of PC3 cells. LWDHD and PCa had a total of 99 common targets, establishing a "drug-ingredient-common target" network. Through GO and KEGG enrichment analysis, PI3K/AKT, MAPK, TP53 pathway, MYC, TNF pathway and other signaling pathways were found. Bioinformatics analysis showed that MYC gene was highly expressed and CCND1 and MAPK1 were low expressed in prostate cancer tissues. In addition, TP53, AKT1, MYC, TNF and CCND1 were positively correlated with MAPK1, among which AKT1 and CCND1 were most closely correlated with MAPK1. Molecular docking results showed that quercetin, kaempferol, β-sitosterol and other main active ingredients of LWDHD treatment for PCa were combined with core proteins MAPK1 and AKT1 well. WB and q-PCR results showed that LWDHD inhibited the expression of PI3K and AKT in PC3 cells.

Conclusion: The mechanism of LWDHD therapy for PCa is a multi-target and multi-pathway complex process, which may be related to the biological processes mediated by MAPK1 and AKT1 pathways, such as cell proliferation and inhibition of metastasis, and the regulation of signaling pathways. The PI3K/AKT signaling pathway may be a central pathway of LWDHD to inhibit prostate cancer proliferation.

目的采用实验验证、网络药理学、生物信息学分析和分子对接等方法,评价六味地黄汤(LWDHD)对前列腺癌(PCa)的抗肿瘤作用机制:方法:采用CCK试验、克隆形成试验和伤口愈合试验确定龙胆泻肝汤对前列腺癌生长和转移的影响。从 TCMSP 数据库中获取 LWDHD 的有效成分和靶点,并从 PCa 的 GeneCards、OMIM 和 DisGeNET 数据库中筛选出相关靶点。将药物与疾病的交叉靶点导入 STRING 数据库,构建蛋白质相互作用网络。还使用 Cytoscape 软件将网络可视化,并使用网络分析器插件筛选核心靶点。使用 R 软件分析了基因本体(GO)和京都基因组百科全书(KEGG)通路富集。TCGA 数据库用于分析生物信息学基因的相关性。使用 AutoDock vina 预测活性成分与关键靶点的分子对接和结合能力。通过WB和q-PCR实验检测上述基因靶点,以验证LWDHD对PCa的作用:结果:CCK和划痕实验证实,LWDHD能抑制前列腺癌细胞的增殖、侵袭和迁移。克隆形成实验表明,LWDHD 可抑制 PC3 细胞的长期增殖能力。LWDHD与PCa共有99个共同靶点,建立了 "药物-成分-共同靶点 "网络。通过GO和KEGG富集分析,发现了PI3K/AKT、MAPK、TP53通路、MYC、TNF通路等信号通路。生物信息学分析表明,前列腺癌组织中 MYC 基因高表达,CCND1 和 MAPK1 低表达。此外,TP53、AKT1、MYC、TNF和CCND1与MAPK1呈正相关,其中AKT1和CCND1与MAPK1的关系最为密切。分子对接结果显示,槲皮素、山柰醇、β-谷甾醇等治疗 PCa 的主要活性成分与核心蛋白 MAPK1 和 AKT1 结合良好。WB和q-PCR结果显示,LWDHD抑制了PC3细胞中PI3K和AKT的表达:LWDHD治疗PCa的机制是一个多靶点、多通路的复杂过程,可能与MAPK1和AKT1通路介导的细胞增殖、抑制转移等生物学过程以及信号通路的调控有关。PI3K/AKT 信号通路可能是 LWDHD 抑制前列腺癌增殖的核心通路。
{"title":"Network pharmacology and experimental validation to explore the role and potential mechanism of Liuwei Dihuang Decoction in prostate cancer.","authors":"Xiangyang Zhan, Haoze Li, Jingyun Jin, Xiran Ju, Jiawei Gao, Xinglin Chen, Fuwen Yuan, Jianyi Gu, DongLiang Xu, Guanqun Ju","doi":"10.1186/s12906-024-04572-5","DOIUrl":"10.1186/s12906-024-04572-5","url":null,"abstract":"<p><strong>Objective: </strong>To evaluate the anti-tumor effector of Liuwei Dihuang Decoction (LWDHD) in prostate cancer (PCa) and explore the potential mechanism using experimental validation, network pharmacology, bioinformatics analysis, and molecular docking.</p><p><strong>Methods: </strong>CCK test, Clone formation assay and wound-healing assays were used to determine the effect of LWDHD on prostate cancer growth and metastasis. The active ingredients and targets of LWDHD were obtained from the TCMSP database, and the relevant targets were selected by GeneCards, OMIM and DisGeNET databases for PCa. The cross-targets of drugs and disease were imported into the STRING database to construct protein interactions. The network was also visualized using Cytoscape software and core targets are screened using the Network Analyzer plug-in. The Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment were analyzed using R software. TCGA database was used to analyze the correlation of bioinformatics genes. AutoDock vina was used to predict the molecular docking and binding ability of active ingredients to key targets. Through WB and q-PCR experiments, the above gene targets were detected to verify the effect of LWDHD on PCa.</p><p><strong>Results: </strong>CCK and scratch tests confirmed that LWDHD could inhibit the proliferation, invasion and migration of prostate cancer cells. Clone formation experiments showed that LWDHD inhibited the long-term proliferative capacity of PC3 cells. LWDHD and PCa had a total of 99 common targets, establishing a \"drug-ingredient-common target\" network. Through GO and KEGG enrichment analysis, PI3K/AKT, MAPK, TP53 pathway, MYC, TNF pathway and other signaling pathways were found. Bioinformatics analysis showed that MYC gene was highly expressed and CCND1 and MAPK1 were low expressed in prostate cancer tissues. In addition, TP53, AKT1, MYC, TNF and CCND1 were positively correlated with MAPK1, among which AKT1 and CCND1 were most closely correlated with MAPK1. Molecular docking results showed that quercetin, kaempferol, β-sitosterol and other main active ingredients of LWDHD treatment for PCa were combined with core proteins MAPK1 and AKT1 well. WB and q-PCR results showed that LWDHD inhibited the expression of PI3K and AKT in PC3 cells.</p><p><strong>Conclusion: </strong>The mechanism of LWDHD therapy for PCa is a multi-target and multi-pathway complex process, which may be related to the biological processes mediated by MAPK1 and AKT1 pathways, such as cell proliferation and inhibition of metastasis, and the regulation of signaling pathways. The PI3K/AKT signaling pathway may be a central pathway of LWDHD to inhibit prostate cancer proliferation.</p>","PeriodicalId":9128,"journal":{"name":"BMC Complementary Medicine and Therapies","volume":null,"pages":null},"PeriodicalIF":3.3,"publicationDate":"2024-07-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11282786/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141765372","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Interprofessional contact with conventional healthcare providers in oncology: a survey among complementary medicine practitioners. 在肿瘤学领域与传统医疗服务提供者的跨专业接触:对辅助医学从业者的调查。
IF 3.3 2区 医学 Q1 INTEGRATIVE & COMPLEMENTARY MEDICINE Pub Date : 2024-07-26 DOI: 10.1186/s12906-024-04563-6
Marit Mentink, Julia Jansen, Janneke Noordman, Liesbeth van Vliet, Martine Busch, Sandra van Dulmen

Background: Half of all patients with cancer use complementary medicine. Given the benefits and risks associated with complementary medicine use, contact between complementary medicine practitioners and conventional healthcare providers (oncologists, nurses) is important for monitoring the health and well-being of mutual patients with cancer. Research on occurrence of such interprofessional contact is scarce. This study aims to describe complementary medicine practitioners' experiences with contact with conventional healthcare providers about mutual patients with cancer and the importance they attach to patient disclosure of complementary medicine use to their conventional healthcare provider. Predictors for interprofessional contact are explored.

Methods: An online survey was administered among complementary medicine practitioners who treat patients with cancer or cancer survivors and who are member of a professional association in the Netherlands.

Results: The survey was completed by 1481 complementary medicine practitioners. 40% of the participants reported to have contact with conventional healthcare providers of patients with cancer. Only 13% of the complementary medicine practitioners experienced conventional healthcare providers as open to communication with them. An explorative logistic regression showed that openness of conventional healthcare providers as experienced by complementary medicine practitioners was the most important predictor for the occurrence of interprofessional contact (OR = 8.12, 95% CI 5.12-12.86, p < .001). Most complementary medicine practitioners (82%) considered it important that patients disclose complementary medicine use to their conventional healthcare provider and 49% of the participants always motivates their patients to do so.

Conclusions: Interprofessional contact with conventional healthcare providers in oncology occurs but is not routine for most complementary medicine practitioners. More than one-third of the surveyed complementary medicine practitioners experienced conventional healthcare providers as not open to communication with them. The openness of conventional healthcare providers as experienced by complementary practitioners is an important predictor for interprofessional contact to take place. Most complementary practitioners acknowledge the importance of patient disclosure of complementary medicine use to their conventional healthcare provider. Open communication about the topic of complementary medicine use between complementary practitioners, conventional healthcare providers and patients prevents overlooking relevant medical information and facilitates optimal monitoring of health and safety of patients with cancer.

背景:半数癌症患者使用辅助药物。鉴于使用辅助药物的益处和风险,辅助药物从业者与传统医疗服务提供者(肿瘤学家、护士)之间的接触对于监测癌症患者的健康和福祉非常重要。有关此类跨专业接触的研究很少。本研究旨在描述辅助医疗从业者与传统医疗服务提供者就共同癌症患者进行接触的经验,以及他们对患者向传统医疗服务提供者披露辅助医疗使用情况的重视程度。研究还探讨了专业间接触的预测因素:方法:对治疗癌症患者或癌症幸存者的辅助医疗从业者进行在线调查,这些从业者都是荷兰一个专业协会的成员:共有 1481 名辅助医学从业人员完成了调查。40%的参与者表示与癌症患者的传统医疗服务提供者有过接触。只有 13% 的辅助医疗从业者认为传统医疗服务提供者愿意与他们沟通。探索性逻辑回归结果显示,辅助医疗从业者认为常规医疗服务提供者的开放程度是预测发生跨专业接触的最重要因素(OR = 8.12,95% CI 5.12-12.86,p 结论:辅助医疗从业者认为常规医疗服务提供者的开放程度是预测发生跨专业接触的最重要因素(OR = 8.12,95% CI 5.12-12.86,p):在肿瘤学领域,与传统医疗服务提供者的跨专业接触时有发生,但对大多数辅助医学从业者来说并非家常便饭。在接受调查的辅助医疗从业者中,超过三分之一的人认为常规医疗服务提供者不愿意与他们交流。辅助医疗从业者认为传统医疗服务提供者的开放程度是进行跨专业接触的一个重要预测因素。大多数辅助医疗从业者都承认,患者向传统医疗服务提供者披露辅助医疗使用情况非常重要。辅助医疗从业者、传统医疗服务提供者和患者之间就辅助医疗的使用问题进行坦诚交流,可以避免忽略相关的医疗信息,有利于对癌症患者的健康和安全进行最佳监控。
{"title":"Interprofessional contact with conventional healthcare providers in oncology: a survey among complementary medicine practitioners.","authors":"Marit Mentink, Julia Jansen, Janneke Noordman, Liesbeth van Vliet, Martine Busch, Sandra van Dulmen","doi":"10.1186/s12906-024-04563-6","DOIUrl":"10.1186/s12906-024-04563-6","url":null,"abstract":"<p><strong>Background: </strong>Half of all patients with cancer use complementary medicine. Given the benefits and risks associated with complementary medicine use, contact between complementary medicine practitioners and conventional healthcare providers (oncologists, nurses) is important for monitoring the health and well-being of mutual patients with cancer. Research on occurrence of such interprofessional contact is scarce. This study aims to describe complementary medicine practitioners' experiences with contact with conventional healthcare providers about mutual patients with cancer and the importance they attach to patient disclosure of complementary medicine use to their conventional healthcare provider. Predictors for interprofessional contact are explored.</p><p><strong>Methods: </strong>An online survey was administered among complementary medicine practitioners who treat patients with cancer or cancer survivors and who are member of a professional association in the Netherlands.</p><p><strong>Results: </strong>The survey was completed by 1481 complementary medicine practitioners. 40% of the participants reported to have contact with conventional healthcare providers of patients with cancer. Only 13% of the complementary medicine practitioners experienced conventional healthcare providers as open to communication with them. An explorative logistic regression showed that openness of conventional healthcare providers as experienced by complementary medicine practitioners was the most important predictor for the occurrence of interprofessional contact (OR = 8.12, 95% CI 5.12-12.86, p < .001). Most complementary medicine practitioners (82%) considered it important that patients disclose complementary medicine use to their conventional healthcare provider and 49% of the participants always motivates their patients to do so.</p><p><strong>Conclusions: </strong>Interprofessional contact with conventional healthcare providers in oncology occurs but is not routine for most complementary medicine practitioners. More than one-third of the surveyed complementary medicine practitioners experienced conventional healthcare providers as not open to communication with them. The openness of conventional healthcare providers as experienced by complementary practitioners is an important predictor for interprofessional contact to take place. Most complementary practitioners acknowledge the importance of patient disclosure of complementary medicine use to their conventional healthcare provider. Open communication about the topic of complementary medicine use between complementary practitioners, conventional healthcare providers and patients prevents overlooking relevant medical information and facilitates optimal monitoring of health and safety of patients with cancer.</p>","PeriodicalId":9128,"journal":{"name":"BMC Complementary Medicine and Therapies","volume":null,"pages":null},"PeriodicalIF":3.3,"publicationDate":"2024-07-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11282773/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141765370","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Antiplasmodial potential of isolated xanthones from Mesua ferrea Linn. roots: an in vitro and in silico molecular docking and pharmacokinetics study. 从Mesua ferrea Linn.根中分离出的黄酮类化合物的抗疟潜力:体外和硅学分子对接与药代动力学研究。
IF 3.3 2区 医学 Q1 INTEGRATIVE & COMPLEMENTARY MEDICINE Pub Date : 2024-07-25 DOI: 10.1186/s12906-024-04580-5
Atthaphon Konyanee, Prapaporn Chaniad, Arnon Chukaew, Apirak Payaka, Abdi Wira Septama, Arisara Phuwajaroanpong, Walaiporn Plirat, Chuchard Punsawad

Background: Malaria is a major global health concern, particularly in tropical and subtropical countries. With growing resistance to first-line treatment with artemisinin, there is an urgent need to discover novel antimalarial drugs. Mesua ferrea Linn., a plant used in traditional medicine for various purposes, has previously been investigated by our research group for its cytotoxic properties. The objective of this study was to explore the compounds isolated from M. ferrea with regards to their potential antiplasmodial activity, their interaction with Plasmodium falciparum lactate dehydrogenase (PfLDH), a crucial enzyme for parasite survival, and their pharmacokinetic and toxicity profiles.

Methods: The isolated compounds were assessed for in vitro antiplasmodial activity against a multidrug-resistant strain of P. falciparum K1 using a parasite lactate dehydrogenase (pLDH) assay. In vitro cytotoxicity against Vero cells was determined using the MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) assay. The interactions between the isolated compounds and the target enzyme PfLDH were investigated using molecular docking. Additionally, pharmacokinetic and toxicity properties were estimated using online web tools SwissADME and ProTox-II, respectively.

Results: Among the seven compounds isolated from M. ferrea roots, rheediachromenoxanthone (5), which belongs to the pyranoxanthone class, demonstrated good in vitro antiplasmodial activity, with the IC50 being 19.93 µM. Additionally, there was no toxicity towards Vero cells (CC50 = 112.34 µM) and a selectivity index (SI) of 5.64. Molecular docking analysis revealed that compound (5) exhibited a strong binding affinity of - 8.6 kcal/mol towards PfLDH and was stabilized by forming hydrogen bonds with key amino acid residues, including ASP53, TYR85, and GLU122. Pharmacokinetic predictions indicated that compound (5) possessed favorable drug-like properties and desired pharmacokinetic characteristics. These include high absorption in the gastrointestinal tract, classification as a non-substrate of permeability glycoprotein (P-gp), non-inhibition of CYP2C19, ease of synthesis, a high predicted LD50 value of 4,000 mg/kg, and importantly, non-hepatotoxic, non-carcinogenic, and non-cytotoxic effects.

Conclusions: This study demonstrated that compounds isolated from M. ferrea exhibit activity against P. falciparum. Rheediachromenoxanthone has significant potential as a scaffold for the development of potent antimalarial drugs.

背景:疟疾是全球主要的健康问题,尤其是在热带和亚热带国家。随着青蒿素一线治疗的抗药性不断增加,迫切需要发现新型抗疟药物。Mesua ferrea Linn.是一种用于各种用途的传统医药植物,我们的研究小组曾对其细胞毒性特性进行过研究。本研究的目的是探索从阿魏中分离出来的化合物的潜在抗疟活性、它们与恶性疟原虫乳酸脱氢酶(PfLDH)的相互作用(PfLDH是寄生虫生存的关键酶)以及它们的药代动力学和毒性特征:方法:利用寄生虫乳酸脱氢酶(pLDH)检测法评估了分离出的化合物对恶性疟原虫 K1 多药耐药菌株的体外抗疟活性。采用 MTT(3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide)试验测定了 Vero 细胞的体外细胞毒性。采用分子对接法研究了分离化合物与目标酶 PfLDH 之间的相互作用。此外,还使用在线网络工具 SwissADME 和 ProTox-II 分别估算了药代动力学和毒性特性:在从阿魏根中分离出的 7 种化合物中,属于吡喃氧杂蒽酮类的 rheediachromenoxanthone (5) 在体外表现出良好的抗疟活性,其 IC50 值为 19.93 µM。此外,该化合物对 Vero 细胞无毒性(CC50 = 112.34 µM),选择性指数(SI)为 5.64。分子对接分析表明,化合物 (5) 与 PfLDH 的结合亲和力为 - 8.6 kcal/mol,并通过与 ASP53、TYR85 和 GLU122 等关键氨基酸残基形成氢键而得到稳定。药代动力学预测表明,化合物 (5) 具有良好的类药物特性和理想的药代动力学特征。这些特征包括在胃肠道的高吸收率、被列为渗透性糖蛋白(P-gp)的非底物、不抑制 CYP2C19、易于合成、预测半数致死剂量高达 4,000 毫克/千克,以及重要的非肝毒性、非致癌性和非细胞毒性作用:这项研究表明,从阿魏中分离出的化合物对恶性疟原虫具有活性。Rheediachromenoxanthone作为开发强效抗疟药物的支架具有巨大潜力。
{"title":"Antiplasmodial potential of isolated xanthones from Mesua ferrea Linn. roots: an in vitro and in silico molecular docking and pharmacokinetics study.","authors":"Atthaphon Konyanee, Prapaporn Chaniad, Arnon Chukaew, Apirak Payaka, Abdi Wira Septama, Arisara Phuwajaroanpong, Walaiporn Plirat, Chuchard Punsawad","doi":"10.1186/s12906-024-04580-5","DOIUrl":"10.1186/s12906-024-04580-5","url":null,"abstract":"<p><strong>Background: </strong>Malaria is a major global health concern, particularly in tropical and subtropical countries. With growing resistance to first-line treatment with artemisinin, there is an urgent need to discover novel antimalarial drugs. Mesua ferrea Linn., a plant used in traditional medicine for various purposes, has previously been investigated by our research group for its cytotoxic properties. The objective of this study was to explore the compounds isolated from M. ferrea with regards to their potential antiplasmodial activity, their interaction with Plasmodium falciparum lactate dehydrogenase (PfLDH), a crucial enzyme for parasite survival, and their pharmacokinetic and toxicity profiles.</p><p><strong>Methods: </strong>The isolated compounds were assessed for in vitro antiplasmodial activity against a multidrug-resistant strain of P. falciparum K1 using a parasite lactate dehydrogenase (pLDH) assay. In vitro cytotoxicity against Vero cells was determined using the MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) assay. The interactions between the isolated compounds and the target enzyme PfLDH were investigated using molecular docking. Additionally, pharmacokinetic and toxicity properties were estimated using online web tools SwissADME and ProTox-II, respectively.</p><p><strong>Results: </strong>Among the seven compounds isolated from M. ferrea roots, rheediachromenoxanthone (5), which belongs to the pyranoxanthone class, demonstrated good in vitro antiplasmodial activity, with the IC<sub>50</sub> being 19.93 µM. Additionally, there was no toxicity towards Vero cells (CC<sub>50</sub> = 112.34 µM) and a selectivity index (SI) of 5.64. Molecular docking analysis revealed that compound (5) exhibited a strong binding affinity of - 8.6 kcal/mol towards PfLDH and was stabilized by forming hydrogen bonds with key amino acid residues, including ASP53, TYR85, and GLU122. Pharmacokinetic predictions indicated that compound (5) possessed favorable drug-like properties and desired pharmacokinetic characteristics. These include high absorption in the gastrointestinal tract, classification as a non-substrate of permeability glycoprotein (P-gp), non-inhibition of CYP2C19, ease of synthesis, a high predicted LD<sub>50</sub> value of 4,000 mg/kg, and importantly, non-hepatotoxic, non-carcinogenic, and non-cytotoxic effects.</p><p><strong>Conclusions: </strong>This study demonstrated that compounds isolated from M. ferrea exhibit activity against P. falciparum. Rheediachromenoxanthone has significant potential as a scaffold for the development of potent antimalarial drugs.</p>","PeriodicalId":9128,"journal":{"name":"BMC Complementary Medicine and Therapies","volume":null,"pages":null},"PeriodicalIF":3.3,"publicationDate":"2024-07-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11270968/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141757141","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Antioxidant activity of polysaccharide from Garcinia mangostana rind and their derivatives. 藤黄果皮多糖及其衍生物的抗氧化活性
IF 3.3 2区 医学 Q1 INTEGRATIVE & COMPLEMENTARY MEDICINE Pub Date : 2024-07-25 DOI: 10.1186/s12906-024-04594-z
Zhenjie Tang, Gangliang Huang

Background: Polysaccharide from Garcinia mangostana rind has many biological activities and deserves further research.

Methods: The antioxidant properties of UAEE-GMRP, UAEE-GMRP-1 A, CM-30, and Ac-30 were evaluated through two different antioxidant activity experimental systems.

Results: The four polysaccharides had a better scavenging effect on hydroxyl radicals, while their inhibitory effect on lipid peroxidation was relatively weak. However, overall, the four polysaccharides showed a certain degree of potential application in the two antioxidant experiments mentioned above, especially the chemically modified polysaccharides from Garcinia mangostana rind, which effectively improved their antioxidant activity. This also indicates that chemical modification is a better method to improve polysaccharide activity. In addition, in these two antioxidant exploration experiments, carboxymethylated polysaccharide showed stronger activity compared to the other three polysaccharides.

Conclusion: The carboxymethylation modification may have great potential for application.

背景从藤黄果皮中提取的多糖具有多种生物活性,值得进一步研究:方法:通过两种不同的抗氧化活性实验体系,评估了 UAEE-GMRP、UAEE-GMRP-1 A、CM-30 和 Ac-30 的抗氧化性:结果:四种多糖对羟自由基有较好的清除作用,而对脂质过氧化的抑制作用相对较弱。但总的来说,这四种多糖在上述两个抗氧化实验中表现出了一定的应用潜力,尤其是经过化学修饰的藤黄果皮多糖,有效提高了其抗氧化活性。这也说明化学修饰是提高多糖活性的较好方法。此外,在这两项抗氧化探索实验中,羧甲基化多糖与其他三种多糖相比表现出更强的活性:结论:羧甲基化改性具有很大的应用潜力。
{"title":"Antioxidant activity of polysaccharide from Garcinia mangostana rind and their derivatives.","authors":"Zhenjie Tang, Gangliang Huang","doi":"10.1186/s12906-024-04594-z","DOIUrl":"10.1186/s12906-024-04594-z","url":null,"abstract":"<p><strong>Background: </strong>Polysaccharide from Garcinia mangostana rind has many biological activities and deserves further research.</p><p><strong>Methods: </strong>The antioxidant properties of UAEE-GMRP, UAEE-GMRP-1 A, CM-30, and Ac-30 were evaluated through two different antioxidant activity experimental systems.</p><p><strong>Results: </strong>The four polysaccharides had a better scavenging effect on hydroxyl radicals, while their inhibitory effect on lipid peroxidation was relatively weak. However, overall, the four polysaccharides showed a certain degree of potential application in the two antioxidant experiments mentioned above, especially the chemically modified polysaccharides from Garcinia mangostana rind, which effectively improved their antioxidant activity. This also indicates that chemical modification is a better method to improve polysaccharide activity. In addition, in these two antioxidant exploration experiments, carboxymethylated polysaccharide showed stronger activity compared to the other three polysaccharides.</p><p><strong>Conclusion: </strong>The carboxymethylation modification may have great potential for application.</p>","PeriodicalId":9128,"journal":{"name":"BMC Complementary Medicine and Therapies","volume":null,"pages":null},"PeriodicalIF":3.3,"publicationDate":"2024-07-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11274750/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141757140","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Protective effects of the R-(+)-thioctic acid treatment: possible anti-inflammatory activity on heart of hypertensive rats. R-(+)-thioctic acid 处理对高血压大鼠心脏的保护作用:可能的抗炎活性。
IF 3.3 2区 医学 Q1 INTEGRATIVE & COMPLEMENTARY MEDICINE Pub Date : 2024-07-24 DOI: 10.1186/s12906-024-04547-6
Proshanta Roy, Daniele Tomassoni, Ilenia Martinelli, Vincenzo Bellitto, Giulio Nittari, Francesco Amenta, Seyed Khosrow Tayebati

Background: In cardiovascular disease, high blood pressure is associated with oxidative stress, promoting endothelial dysfunction, vascular remodeling, and inflammation. Clinical trials are discordant that the most effective treatment in the management of hypertension seems to be the administration of anti-hypertensive drugs with antioxidant properties. The study aims to evaluate the effects of the eutomer of thioctic acid on oxidative stress and inflammation in the heart of spontaneously hypertensive rats compared to normotensive Wistar Kyoto rats.

Methods: To study the oxidative status, the malondialdehyde and 4-hydroxynonenal concentration, protein oxidation were measured in the heart. Morphological analysis were performed. Immunohistochemistry and Western blot were done for alpha-smooth muscle actin and transforming growth factor beta to assess fibrosis; cytokines and nuclear factor kappaB to assess inflammatory processes.

Results: Spontaneously hypertensive rats were characterized by hypertension with increased malondialdehyde levels in the heart. OxyBlot in the heart of spontaneously hypertensive rats showed an increase in proteins' oxidative status. Cardiomyocyte hypertrophy and fibrosis in the ventricles were associated with an increased expression of alpha-smooth muscle actin and pro-inflammatory cytokines, reduced by the eutomer of thioctic acid supplementation.

Conclusions: Based on this evidence, eutomer of thioctic acid could represent an appropriate antioxidant molecule to reduce oxidative stress and prevent inflammatory processes on the cardiomyocytes and cardiac vascular endothelium.

背景:在心血管疾病中,高血压与氧化应激有关,会促进内皮功能障碍、血管重塑和炎症。临床试验表明,治疗高血压最有效的方法似乎是服用具有抗氧化特性的抗高血压药物。本研究旨在评估硫辛酸的同分异构体对自发性高血压大鼠心脏氧化应激和炎症的影响,并与正常血压的 Wistar Kyoto 大鼠进行比较:为了研究氧化状态,测量了心脏中丙二醛和 4-羟基壬烯醛的浓度以及蛋白质氧化情况。进行形态学分析。免疫组化和 Western 印迹法检测α-平滑肌肌动蛋白和转化生长因子β,以评估纤维化情况;检测细胞因子和核因子 kappaB,以评估炎症过程:自发性高血压大鼠以高血压为特征,心脏中丙二醛水平升高。自发性高血压大鼠心脏中的 OxyBlot 显示蛋白质氧化状态增加。心肌细胞肥大和心室纤维化与α-平滑肌肌动蛋白和促炎症细胞因子的表达增加有关,而补充硫辛酸的同系物可减少这种现象:基于这些证据,硫辛酸的同系物可能是一种适当的抗氧化分子,可减少氧化应激,防止心肌细胞和心脏血管内皮细胞的炎症过程。
{"title":"Protective effects of the R-(+)-thioctic acid treatment: possible anti-inflammatory activity on heart of hypertensive rats.","authors":"Proshanta Roy, Daniele Tomassoni, Ilenia Martinelli, Vincenzo Bellitto, Giulio Nittari, Francesco Amenta, Seyed Khosrow Tayebati","doi":"10.1186/s12906-024-04547-6","DOIUrl":"10.1186/s12906-024-04547-6","url":null,"abstract":"<p><strong>Background: </strong>In cardiovascular disease, high blood pressure is associated with oxidative stress, promoting endothelial dysfunction, vascular remodeling, and inflammation. Clinical trials are discordant that the most effective treatment in the management of hypertension seems to be the administration of anti-hypertensive drugs with antioxidant properties. The study aims to evaluate the effects of the eutomer of thioctic acid on oxidative stress and inflammation in the heart of spontaneously hypertensive rats compared to normotensive Wistar Kyoto rats.</p><p><strong>Methods: </strong>To study the oxidative status, the malondialdehyde and 4-hydroxynonenal concentration, protein oxidation were measured in the heart. Morphological analysis were performed. Immunohistochemistry and Western blot were done for alpha-smooth muscle actin and transforming growth factor beta to assess fibrosis; cytokines and nuclear factor kappaB to assess inflammatory processes.</p><p><strong>Results: </strong>Spontaneously hypertensive rats were characterized by hypertension with increased malondialdehyde levels in the heart. OxyBlot in the heart of spontaneously hypertensive rats showed an increase in proteins' oxidative status. Cardiomyocyte hypertrophy and fibrosis in the ventricles were associated with an increased expression of alpha-smooth muscle actin and pro-inflammatory cytokines, reduced by the eutomer of thioctic acid supplementation.</p><p><strong>Conclusions: </strong>Based on this evidence, eutomer of thioctic acid could represent an appropriate antioxidant molecule to reduce oxidative stress and prevent inflammatory processes on the cardiomyocytes and cardiac vascular endothelium.</p>","PeriodicalId":9128,"journal":{"name":"BMC Complementary Medicine and Therapies","volume":null,"pages":null},"PeriodicalIF":3.3,"publicationDate":"2024-07-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11267948/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141757142","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Bringing back Galium aparine L. from forgotten corners of traditional wound treatment procedures: an antimicrobial, antioxidant, and in-vitro wound healing assay along with HPTLC fingerprinting study. 从传统伤口处理程序中被遗忘的角落带回天冬属植物:抗菌、抗氧化和体外伤口愈合测定以及 HPTLC 指纹研究。
IF 3.3 2区 医学 Q1 INTEGRATIVE & COMPLEMENTARY MEDICINE Pub Date : 2024-07-23 DOI: 10.1186/s12906-024-04355-y
Amirreza Dowlati Beirami, Negin Akhtari, Razieh Noroozi, Dara Hatamabadi, Syed Muhammad Farid Hasan, Seyed Abdulmajid Ayatollahi, Neda Alsadat Ayatollahi, Farzad Kobarfard

Background: The wound healing process, restoring the functionality of the damaged tissue, can be accelerated by various compounds. The recent experimental analysis highlights the beneficial effects of phytochemicals in improving skin regeneration and wound healing. In traditional medicine, one of the widespread plants used for treating different injuries or skin afflictions is Galium aparine L. (GA). Besides, previously reported chemical compounds of GA suggested its therapeutic effects for the wound healing process, yet its regulatory effects on the cellular and molecular stages of the wound healing process have not been investigated.

Methods: In the present study, the phytochemical profile of the GA extract was analyzed using HPTLC fingerprinting, and further scientific evaluation of its phytochemicals was done. The wound-healing effects of GA extract were explored at the cellular and molecular levels while accounting for cell toxicity. The wound closure enhancing effect, antibacterial activity, and antioxidant activity were assessed.

Results: The HPTLC fingerprinting of the GA extract proved its previously reported phytochemical profile including phenols, flavonoids, tannins, plant acids, ergot alkaloids, flavonoids, anthraquinones, terpenoids, sterols, salicin, lipophilic compounds, saponins, iridoids, and heterocyclic nitrogen compounds. Antimicrobial assessment, of the extract, indicated the more susceptibility of S. aureus to the inhibitory effects of GA rather than E. coli and S. epidermidis. DPPH test results revealed the antioxidant property of GA extract, which was comparable to ascorbic acid. The results of the viability assay showed no cytotoxicity effects on human umbilical endothelial cell (HUVEC) and normal human dermal fibroblast (NHDF) cell lines treated with different concentrations of whole plant extract and cell viability increased in a dose-dependent manner. The results of the scratch assay showed improved cell migration and wound closure.

Conclusions: This study shows the anti-oxidant, anti-microbial, and in vitro wound healing wound-healing effects of GA hydroalcoholic extract, which aligns with its use in traditional medicine. No cytotoxicity effects were shown. The results from this study can be the basis for further investigations such as animal models and phytochemical studies. Further evaluation of its effects on mechanisms and signaling pathways involved in the wound healing processes such as angiogenesis and cell proliferation can provide novel insights into the potential therapeutic effects of the GA extract.

背景:各种化合物可加速伤口愈合过程,恢复受损组织的功能。最近的实验分析凸显了植物化学物质在改善皮肤再生和伤口愈合方面的有益作用。在传统医学中,天冬酰胺(Galium aparine L.,GA)是一种广泛用于治疗不同创伤或皮肤病的植物。此外,之前报道的 GA 化合物表明其对伤口愈合过程具有治疗作用,但其对伤口愈合过程的细胞和分子阶段的调节作用尚未得到研究:本研究采用 HPTLC 指纹图谱对天麻提取物的植物化学成分进行了分析,并对其植物化学成分做了进一步的科学评价。在考虑细胞毒性的同时,从细胞和分子水平探讨了 GA 提取物的伤口愈合效果。结果:GA 提取物的 HPTLC指纹图谱显示,GA 提取物的抗菌活性、抗氧化活性和伤口愈合效果均优于其他提取物:结果:GA 提取物的 HPTLC指纹图谱证明了之前报道的植物化学特征,包括酚类、黄酮类、单宁酸、植物酸、麦角生物碱、黄酮类、蒽醌类、萜类、甾醇类、水杨酸、亲脂性化合物、皂苷类、虹彩类和杂环氮化合物。提取物的抗菌评估表明,金黄色葡萄球菌对 GA 的抑制作用更敏感,而大肠杆菌和表皮葡萄球菌则更敏感。DPPH 试验结果表明,GA 提取物的抗氧化性与抗坏血酸相当。细胞活力测定结果表明,不同浓度的全植物萃取物对人脐带内皮细胞(HUVEC)和正常人真皮成纤维细胞(NHDF)没有细胞毒性作用,细胞活力的增加呈剂量依赖性。划痕试验结果表明,细胞迁移和伤口闭合得到改善:本研究表明,天麻水醇提取物具有抗氧化、抗微生物和体外伤口愈合的作用,这与天麻在传统医学中的用途一致。没有显示出细胞毒性效应。本研究的结果可作为动物模型和植物化学研究等进一步研究的基础。进一步评估其对伤口愈合过程(如血管生成和细胞增殖)所涉及的机制和信号通路的影响,可为了解天麻提取物的潜在治疗效果提供新的视角。
{"title":"Bringing back Galium aparine L. from forgotten corners of traditional wound treatment procedures: an antimicrobial, antioxidant, and in-vitro wound healing assay along with HPTLC fingerprinting study.","authors":"Amirreza Dowlati Beirami, Negin Akhtari, Razieh Noroozi, Dara Hatamabadi, Syed Muhammad Farid Hasan, Seyed Abdulmajid Ayatollahi, Neda Alsadat Ayatollahi, Farzad Kobarfard","doi":"10.1186/s12906-024-04355-y","DOIUrl":"10.1186/s12906-024-04355-y","url":null,"abstract":"<p><strong>Background: </strong>The wound healing process, restoring the functionality of the damaged tissue, can be accelerated by various compounds. The recent experimental analysis highlights the beneficial effects of phytochemicals in improving skin regeneration and wound healing. In traditional medicine, one of the widespread plants used for treating different injuries or skin afflictions is Galium aparine L. (GA). Besides, previously reported chemical compounds of GA suggested its therapeutic effects for the wound healing process, yet its regulatory effects on the cellular and molecular stages of the wound healing process have not been investigated.</p><p><strong>Methods: </strong>In the present study, the phytochemical profile of the GA extract was analyzed using HPTLC fingerprinting, and further scientific evaluation of its phytochemicals was done. The wound-healing effects of GA extract were explored at the cellular and molecular levels while accounting for cell toxicity. The wound closure enhancing effect, antibacterial activity, and antioxidant activity were assessed.</p><p><strong>Results: </strong>The HPTLC fingerprinting of the GA extract proved its previously reported phytochemical profile including phenols, flavonoids, tannins, plant acids, ergot alkaloids, flavonoids, anthraquinones, terpenoids, sterols, salicin, lipophilic compounds, saponins, iridoids, and heterocyclic nitrogen compounds. Antimicrobial assessment, of the extract, indicated the more susceptibility of S. aureus to the inhibitory effects of GA rather than E. coli and S. epidermidis. DPPH test results revealed the antioxidant property of GA extract, which was comparable to ascorbic acid. The results of the viability assay showed no cytotoxicity effects on human umbilical endothelial cell (HUVEC) and normal human dermal fibroblast (NHDF) cell lines treated with different concentrations of whole plant extract and cell viability increased in a dose-dependent manner. The results of the scratch assay showed improved cell migration and wound closure.</p><p><strong>Conclusions: </strong>This study shows the anti-oxidant, anti-microbial, and in vitro wound healing wound-healing effects of GA hydroalcoholic extract, which aligns with its use in traditional medicine. No cytotoxicity effects were shown. The results from this study can be the basis for further investigations such as animal models and phytochemical studies. Further evaluation of its effects on mechanisms and signaling pathways involved in the wound healing processes such as angiogenesis and cell proliferation can provide novel insights into the potential therapeutic effects of the GA extract.</p>","PeriodicalId":9128,"journal":{"name":"BMC Complementary Medicine and Therapies","volume":null,"pages":null},"PeriodicalIF":3.3,"publicationDate":"2024-07-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11267910/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141751072","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Integrated network pharmacology and bioinformatics to identify therapeutic targets and molecular mechanisms of Huangkui Lianchang Decoction for ulcerative colitis treatment. 整合网络药理学和生物信息学,确定黄葵连翘煎剂治疗溃疡性结肠炎的靶点和分子机制。
IF 3.3 2区 医学 Q1 INTEGRATIVE & COMPLEMENTARY MEDICINE Pub Date : 2024-07-23 DOI: 10.1186/s12906-024-04590-3
Zongqi He, Xiang Xu, Yugen Chen, Yuyu Huang, Bensheng Wu, Zhizhong Xu, Jun Du, Qing Zhou, Xudong Cheng

Background: Huangkui Lianchang Decoction (HLD) is a traditional Chinese herbal formula for treating ulcerative colitis (UC). However, its mechanism of action remains poorly understood. The Study aims to validate the therapeutic effect of HLD on UC and its mechanism by integrating network pharmacology, bioinformatics, and experimental validation.

Methods: UC targets were collected by databases and GSE19101. The active ingredients in HLD were detected by ultra-performance liquid chromatography-tandem mass spectrometry. PubChem collected targets of active ingredients. Protein-protein interaction (PPI) networks were established with UC-related targets. Gene Ontology and Kyoto Encyclopedia (KEGG) of Genes and Genomes enrichment were analyzed for the mechanism of HLD treatment of UC and validated by the signaling pathways of HLD. Effects of HLD on UC were verified using dextran sulfate sodium (DDS)-induced UC mice experiments.

Results: A total of 1883 UC-related targets were obtained from the GSE10191 dataset, 1589 from the database, and 1313 matching HLD-related targets, for a total of 94 key targets. Combined with PPI, GO, and KEGG network analyses, the signaling pathways were enriched to obtain IL-17, Toll-like receptor, NF-κB, and tumor necrosis factor signaling pathways. In animal experiments, HLD improved the inflammatory response of UC and reduced UC-induced pro-inflammatory factors such as Tumor Necrosis Factor Alpha (TNF-α), interleukin 1β (IL-1β), and interleukin 6 (IL-6). HLD suppressed proteins TLR4, MyD88, and NF-κB expression.

Conclusions: This study systematically dissected the molecular mechanism of HLD for the treatment of UC using a network pharmacology approach. Further animal verification experiments revealed that HLD inhibited inflammatory responses and improved intestinal barrier function through the TLR4/MyD88/NF-κB pathway.

背景:黄葵连翘煎是治疗溃疡性结肠炎(UC)的传统中药配方。然而,人们对其作用机制仍知之甚少。本研究旨在通过整合网络药理学、生物信息学和实验验证,验证黄酮连翘煎剂对溃疡性结肠炎的治疗作用及其机制:方法:通过数据库和 GSE19101 收集 UC 靶点。方法:通过数据库和 GSE19101 收集 UC 靶点,采用超高效液相色谱-串联质谱法检测 HLD 中的有效成分。PubChem 收集了活性成分的靶标。用 UC 相关靶标建立了蛋白质-蛋白质相互作用(PPI)网络。基因本体和京都基因组百科全书(KEGG)分析了HLD治疗UC的机制,并通过HLD的信号通路进行了验证。通过右旋糖酐硫酸钠(DDS)诱导的UC小鼠实验验证了HLD对UC的影响:结果:从GSE10191数据集中共获得1883个UC相关靶点,其中1589个来自数据库,1313个匹配HLD相关靶点,共计94个关键靶点。结合PPI、GO和KEGG网络分析,对信号通路进行了富集,得到了IL-17、Toll样受体、NF-κB和肿瘤坏死因子信号通路。在动物实验中,HLD改善了UC的炎症反应,减少了UC诱导的促炎因子,如肿瘤坏死因子α(TNF-α)、白细胞介素1β(IL-1β)和白细胞介素6(IL-6)。HLD抑制了蛋白质TLR4、MyD88和NF-κB的表达:本研究采用网络药理学方法系统地剖析了HLD治疗UC的分子机制。进一步的动物验证实验表明,HLD可通过TLR4/MyD88/NF-κB途径抑制炎症反应并改善肠道屏障功能。
{"title":"Integrated network pharmacology and bioinformatics to identify therapeutic targets and molecular mechanisms of Huangkui Lianchang Decoction for ulcerative colitis treatment.","authors":"Zongqi He, Xiang Xu, Yugen Chen, Yuyu Huang, Bensheng Wu, Zhizhong Xu, Jun Du, Qing Zhou, Xudong Cheng","doi":"10.1186/s12906-024-04590-3","DOIUrl":"10.1186/s12906-024-04590-3","url":null,"abstract":"<p><strong>Background: </strong>Huangkui Lianchang Decoction (HLD) is a traditional Chinese herbal formula for treating ulcerative colitis (UC). However, its mechanism of action remains poorly understood. The Study aims to validate the therapeutic effect of HLD on UC and its mechanism by integrating network pharmacology, bioinformatics, and experimental validation.</p><p><strong>Methods: </strong>UC targets were collected by databases and GSE19101. The active ingredients in HLD were detected by ultra-performance liquid chromatography-tandem mass spectrometry. PubChem collected targets of active ingredients. Protein-protein interaction (PPI) networks were established with UC-related targets. Gene Ontology and Kyoto Encyclopedia (KEGG) of Genes and Genomes enrichment were analyzed for the mechanism of HLD treatment of UC and validated by the signaling pathways of HLD. Effects of HLD on UC were verified using dextran sulfate sodium (DDS)-induced UC mice experiments.</p><p><strong>Results: </strong>A total of 1883 UC-related targets were obtained from the GSE10191 dataset, 1589 from the database, and 1313 matching HLD-related targets, for a total of 94 key targets. Combined with PPI, GO, and KEGG network analyses, the signaling pathways were enriched to obtain IL-17, Toll-like receptor, NF-κB, and tumor necrosis factor signaling pathways. In animal experiments, HLD improved the inflammatory response of UC and reduced UC-induced pro-inflammatory factors such as Tumor Necrosis Factor Alpha (TNF-α), interleukin 1β (IL-1β), and interleukin 6 (IL-6). HLD suppressed proteins TLR4, MyD88, and NF-κB expression.</p><p><strong>Conclusions: </strong>This study systematically dissected the molecular mechanism of HLD for the treatment of UC using a network pharmacology approach. Further animal verification experiments revealed that HLD inhibited inflammatory responses and improved intestinal barrier function through the TLR4/MyD88/NF-κB pathway.</p>","PeriodicalId":9128,"journal":{"name":"BMC Complementary Medicine and Therapies","volume":null,"pages":null},"PeriodicalIF":3.3,"publicationDate":"2024-07-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11267728/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141751073","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Formulation of 1% α-mangostin in orabase gel induces apoptosis in oral squamous cell carcinoma. 将 1%α-曼戈斯汀加入口腔凝胶中可诱导口腔鳞状细胞癌细胞凋亡。
IF 3.3 2区 医学 Q1 INTEGRATIVE & COMPLEMENTARY MEDICINE Pub Date : 2024-07-20 DOI: 10.1186/s12906-024-04450-0
Wipawee Nittayananta, Teerapol Srichana, Jureeporn Chuerduangphui, Ekarat Hitakomate, Kesinee Netsomboon

Background: Plant-derived compounds have chemopreventive properties to be used as alternative medicine. Pericarp of Mangosteen (Garcinia mangostana Linn.), a tropical fruit in Southeast Asia contains a phytochemical α-mangostin (α-MG) that demonstrates potent anticancer effects against various types of cancer. α-MG has been reported to be the most effective agent in human cancer cell lines. The objectives of this study were to develop oral gel formulations containing α-MG and determine their (1) anticancer activity, (2) anti-HPV-16 and antimicrobial activities, (3) nitric oxide (NO) inhibitory activity, and (4) wound healing effect.

Methods: Formulations of oral gel containing α-MG were developed. Anticancer activity on SCC-25 was assessed. Apoptotic induction was determined using flow cytometry technique. Antiviral activity against HPV-16 pseudovirus and antimicrobial activity against S. mutans, P. gingivalis and C. albicans were investigated. NO inhibition was carried out. Fibroblast cell migration was determined by in vitro scratch assay.

Results: The formulation of 1% α-MG in orabase gel demonstrated anticancer activity by promoting apoptosis in SCC-25. The induction of apoptotic activity was dose dependent with pronounced effect in late apoptosis. The formulation appeared to reduce cell viability of oral keratinocytes (OKC). At CC50 it showed an inhibition against HPV-16 pseudovirus infection. The formulation had no antimicrobial activity against S. mutans, P. gingivalis and C. albicans. No significant NO inhibitory activity and wound healing effects were found.

Conclusions: 1% α-MG in orabase gel exhibited anticancer activity by inducing apoptosis although low level of cytotoxicity observed in OKC was present. The appropriate carrier for novel nano-particles targeting cancer cells should be further investigated.

背景:植物提取的化合物具有化学预防特性,可用作替代药物。山竹果(Garcinia mangostana Linn.)是东南亚的一种热带水果,其果皮含有一种植物化学物质α-mangostin(α-MG),对各种类型的癌症有很强的抗癌作用。本研究的目的是开发含 α-MG 的口服凝胶配方,并确定其(1)抗癌活性;(2)抗 HPV-16 和抗菌活性;(3)一氧化氮(NO)抑制活性;以及(4)伤口愈合效果:方法:研制了含有 α-MG 的口服凝胶配方。评估了对 SCC-25 的抗癌活性。采用流式细胞术测定凋亡诱导。研究了对 HPV-16 伪病毒的抗病毒活性,以及对突变体、牙龈球菌和白喉杆菌的抗菌活性。进行了 NO 抑制实验。体外划痕试验测定了成纤维细胞的迁移:结果:含 1%α-MG的 orabase 凝胶配方具有抗癌活性,能促进 SCC-25 细胞凋亡。诱导细胞凋亡的活性与剂量有关,对晚期细胞凋亡有明显影响。该制剂似乎降低了口腔角朊细胞(OKC)的细胞活力。在 CC50 时,它对 HPV-16 伪病毒感染有抑制作用。该制剂对突变杆状病毒、牙龈球菌和白喉杆菌没有抗菌活性。没有发现明显的 NO 抑制活性和伤口愈合效果:结论:尽管在 OKC 中观察到的细胞毒性水平较低,但 orabase 凝胶中的 1%α-MG 具有诱导细胞凋亡的抗癌活性。针对癌细胞的新型纳米粒子的适当载体有待进一步研究。
{"title":"Formulation of 1% α-mangostin in orabase gel induces apoptosis in oral squamous cell carcinoma.","authors":"Wipawee Nittayananta, Teerapol Srichana, Jureeporn Chuerduangphui, Ekarat Hitakomate, Kesinee Netsomboon","doi":"10.1186/s12906-024-04450-0","DOIUrl":"10.1186/s12906-024-04450-0","url":null,"abstract":"<p><strong>Background: </strong>Plant-derived compounds have chemopreventive properties to be used as alternative medicine. Pericarp of Mangosteen (Garcinia mangostana Linn.), a tropical fruit in Southeast Asia contains a phytochemical α-mangostin (α-MG) that demonstrates potent anticancer effects against various types of cancer. α-MG has been reported to be the most effective agent in human cancer cell lines. The objectives of this study were to develop oral gel formulations containing α-MG and determine their (1) anticancer activity, (2) anti-HPV-16 and antimicrobial activities, (3) nitric oxide (NO) inhibitory activity, and (4) wound healing effect.</p><p><strong>Methods: </strong>Formulations of oral gel containing α-MG were developed. Anticancer activity on SCC-25 was assessed. Apoptotic induction was determined using flow cytometry technique. Antiviral activity against HPV-16 pseudovirus and antimicrobial activity against S. mutans, P. gingivalis and C. albicans were investigated. NO inhibition was carried out. Fibroblast cell migration was determined by in vitro scratch assay.</p><p><strong>Results: </strong>The formulation of 1% α-MG in orabase gel demonstrated anticancer activity by promoting apoptosis in SCC-25. The induction of apoptotic activity was dose dependent with pronounced effect in late apoptosis. The formulation appeared to reduce cell viability of oral keratinocytes (OKC). At CC<sub>50</sub> it showed an inhibition against HPV-16 pseudovirus infection. The formulation had no antimicrobial activity against S. mutans, P. gingivalis and C. albicans. No significant NO inhibitory activity and wound healing effects were found.</p><p><strong>Conclusions: </strong>1% α-MG in orabase gel exhibited anticancer activity by inducing apoptosis although low level of cytotoxicity observed in OKC was present. The appropriate carrier for novel nano-particles targeting cancer cells should be further investigated.</p>","PeriodicalId":9128,"journal":{"name":"BMC Complementary Medicine and Therapies","volume":null,"pages":null},"PeriodicalIF":3.3,"publicationDate":"2024-07-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11264970/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141733596","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A scoping review of over-the-counter products for depression, anxiety and insomnia in older people. 对治疗老年人抑郁、焦虑和失眠的非处方产品进行范围审查。
IF 3.3 2区 医学 Q1 INTEGRATIVE & COMPLEMENTARY MEDICINE Pub Date : 2024-07-20 DOI: 10.1186/s12906-024-04585-0
Rachael Frost, Silvy Mathew, Verity Thomas, Sayem Uddin, Adriana Salame, Christine Vial, Tanya Cohen, Sukvinder Kaur Bhamra, Juan Carlos Bazo Alvarez, Cini Bhanu, Michael Heinrich, Kate Walters

Background: Depression, anxiety, and insomnia are prevalent in older people and are associated with increased risk of mortality, dependency, falls and reduced quality of life. Prior to or whilst seeking treatment, older people often manage these symptoms or conditions using products purchased over the counter (OTC), such as medication or herbal products. This review aims to map the evidence available for OTC medications, herbal medicines and dietary supplements for depression, anxiety and insomnia in older adults.

Methodology: We carried out a scoping review, including searches of five databases to identify relevant randomised controlled trials (inception-Dec 2022). We took an inclusive approach to products to represent the wide range that may be available online. Trials were summarised according to condition and product.

Results: We included 47 trials and 10 ongoing trial protocols. Most targeted insomnia (n = 25), followed by depression (n = 20), and mixed conditions (n = 2). None evaluated products targeted at anxiety alone. Where reported, most products appeared to be safe for use, but studies rarely included people with multiple comorbidities or taking concomitant medication. Some types of melatonin for insomnia (n = 19) and omega-3 fatty acids for depression (n = 7) had more substantive evidence compared to the other products.

Conclusion: There is a substantial gap in evidence for OTC products for anxiety in older people. This should be addressed in future trials. Research should also focus on products that are widely used, and these need to be tested in older populations that are similar to those who would use them in practice.

背景:抑郁、焦虑和失眠在老年人中很普遍,与死亡率、依赖性、跌倒和生活质量下降的风险增加有关。在寻求治疗之前或治疗期间,老年人通常会使用非处方药(OTC)产品(如药物或草药产品)来控制这些症状或病症。本综述旨在对老年人使用非处方药物、草药和膳食补充剂治疗抑郁、焦虑和失眠的现有证据进行梳理:我们进行了一次范围界定综述,包括搜索五个数据库,以确定相关的随机对照试验(inception-Dec 2022)。我们对产品采取了包容性的方法,以代表网上可能存在的广泛范围。根据条件和产品对试验进行了总结:我们纳入了 47 项试验和 10 项正在进行的试验方案。大多数试验针对失眠症(25 项),其次是抑郁症(20 项)和混合症状(2 项)。没有一项试验只评估了针对焦虑症的产品。在报告中,大多数产品的使用似乎是安全的,但研究很少包括患有多种并发症或同时服用药物的人群。与其他产品相比,某些类型的治疗失眠的褪黑素(n = 19)和治疗抑郁症的欧米伽-3脂肪酸(n = 7)拥有更多实质性证据:结论:治疗老年人焦虑症的非处方药产品在证据方面存在很大差距。今后的试验应解决这一问题。研究还应关注那些被广泛使用的产品,这些产品需要在与实际使用人群相似的老年人群中进行测试。
{"title":"A scoping review of over-the-counter products for depression, anxiety and insomnia in older people.","authors":"Rachael Frost, Silvy Mathew, Verity Thomas, Sayem Uddin, Adriana Salame, Christine Vial, Tanya Cohen, Sukvinder Kaur Bhamra, Juan Carlos Bazo Alvarez, Cini Bhanu, Michael Heinrich, Kate Walters","doi":"10.1186/s12906-024-04585-0","DOIUrl":"10.1186/s12906-024-04585-0","url":null,"abstract":"<p><strong>Background: </strong>Depression, anxiety, and insomnia are prevalent in older people and are associated with increased risk of mortality, dependency, falls and reduced quality of life. Prior to or whilst seeking treatment, older people often manage these symptoms or conditions using products purchased over the counter (OTC), such as medication or herbal products. This review aims to map the evidence available for OTC medications, herbal medicines and dietary supplements for depression, anxiety and insomnia in older adults.</p><p><strong>Methodology: </strong>We carried out a scoping review, including searches of five databases to identify relevant randomised controlled trials (inception-Dec 2022). We took an inclusive approach to products to represent the wide range that may be available online. Trials were summarised according to condition and product.</p><p><strong>Results: </strong>We included 47 trials and 10 ongoing trial protocols. Most targeted insomnia (n = 25), followed by depression (n = 20), and mixed conditions (n = 2). None evaluated products targeted at anxiety alone. Where reported, most products appeared to be safe for use, but studies rarely included people with multiple comorbidities or taking concomitant medication. Some types of melatonin for insomnia (n = 19) and omega-3 fatty acids for depression (n = 7) had more substantive evidence compared to the other products.</p><p><strong>Conclusion: </strong>There is a substantial gap in evidence for OTC products for anxiety in older people. This should be addressed in future trials. Research should also focus on products that are widely used, and these need to be tested in older populations that are similar to those who would use them in practice.</p>","PeriodicalId":9128,"journal":{"name":"BMC Complementary Medicine and Therapies","volume":null,"pages":null},"PeriodicalIF":3.3,"publicationDate":"2024-07-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11264918/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141733595","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
BMC Complementary Medicine and Therapies
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1